241 related articles for article (PubMed ID: 12713586)
1. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
Zaiou M; Nizet V; Gallo RL
J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
[TBL] [Abstract][Full Text] [Related]
2. The LL-37 domain: A clue to cathelicidin immunomodulatory response?
Leite ML; Duque HM; Rodrigues GR; da Cunha NB; Franco OL
Peptides; 2023 Jul; 165():171011. PubMed ID: 37068711
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells of human whole saliva.
Aidoukovitch A; Dahl S; Fält F; Nebel D; Svensson D; Tufvesson E; Nilsson BO
Eur J Oral Sci; 2020 Feb; 128(1):1-6. PubMed ID: 31825534
[TBL] [Abstract][Full Text] [Related]
4. The cysteine protease ApdS from
Xie F; Zan Y; Zhang Y; Zheng N; Yan Q; Zhang W; Zhang H; Jin M; Chen F; Zhang X; Liu S
J Biol Chem; 2019 Nov; 294(47):17962-17977. PubMed ID: 31619521
[No Abstract] [Full Text] [Related]
5. The host defense peptide LL-37 is detected in human parotid and submandibular/sublingual saliva and expressed in glandular neutrophils.
Svensson D; Aidoukovitch A; Anders E; Agerberth B; Andersson F; Ekblad E; Ericson D; Nebel D; Voss U; Nilsson BO
Eur J Oral Sci; 2018 Apr; 126(2):93-100. PubMed ID: 29424090
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced human osteoblast cytotoxicity.
Aidoukovitch A; Bankell E; Svensson D; Nilsson BO
Biochem Biophys Res Commun; 2024 Jun; 712-713():149962. PubMed ID: 38642493
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
[TBL] [Abstract][Full Text] [Related]
8. Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.
Dong X; Zhang W; Hou J; Ma M; Zhu C; Wang H; Hou S
Med Sci Monit; 2020 Jul; 26():e923909. PubMed ID: 32634134
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.
Narayana JL; Mishra B; Lushnikova T; Golla RM; Wang G
Biochim Biophys Acta Biomembr; 2019 Sep; 1861(9):1592-1602. PubMed ID: 31319057
[TBL] [Abstract][Full Text] [Related]
10. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E
Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
FASEB J; 2018 May; 32(5):2827-2840. PubMed ID: 29401596
[TBL] [Abstract][Full Text] [Related]
12. Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis.
Turkoglu O; Emingil G; Eren G; Atmaca H; Kutukculer N; Atilla G
Clin Oral Investig; 2017 Apr; 21(3):763-769. PubMed ID: 27129587
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of RN15m4 Cathelin Domain-Based Peptides from Siamese Crocodile Cathelicidin Improves Antimicrobial Activity.
Jangpromma N; Konkchaiyaphum M; Punpad A; Sosiangdi S; Daduang S; Klaynongsruang S; Tankrathok A
Appl Biochem Biotechnol; 2023 Feb; 195(2):1096-1108. PubMed ID: 36327032
[TBL] [Abstract][Full Text] [Related]
14. Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37.
Lakshmaiah Narayana J; Golla R; Mishra B; Wang X; Lushnikova T; Zhang Y; Verma A; Kumar V; Xie J; Wang G
ACS Infect Dis; 2021 Jun; 7(6):1795-1808. PubMed ID: 33890759
[TBL] [Abstract][Full Text] [Related]
15. SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice.
Lee IH; Jung YJ; Cho YG; Nou IS; Huq MA; Nogoy FM; Kang KK
PLoS One; 2017; 12(3):e0172936. PubMed ID: 28282452
[TBL] [Abstract][Full Text] [Related]
16. Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing.
LaRock CN; Döhrmann S; Todd J; Corriden R; Olson J; Johannssen T; Lepenies B; Gallo RL; Ghosh P; Nizet V
Cell Host Microbe; 2015 Oct; 18(4):471-7. PubMed ID: 26468750
[TBL] [Abstract][Full Text] [Related]
17. Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration.
Findlay F; Pohl J; Svoboda P; Shakamuri P; McLean K; Inglis NF; Proudfoot L; Barlow PG
J Immunol; 2017 Oct; 199(7):2483-2490. PubMed ID: 28814602
[TBL] [Abstract][Full Text] [Related]
18. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides.
Hollands A; Gonzalez D; Leire E; Donald C; Gallo RL; Sanderson-Smith M; Dorrestein PC; Nizet V
J Biol Chem; 2012 Nov; 287(49):40891-7. PubMed ID: 23038245
[TBL] [Abstract][Full Text] [Related]
19. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.
Le J; Dam Q; Schweizer M; Thienphrapa W; Nizet V; Sakoulas G
Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1441-7. PubMed ID: 27234592
[TBL] [Abstract][Full Text] [Related]
20. Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.
Kulkarni NN; O'Neill AM; Dokoshi T; Luo EWC; Wong GCL; Gallo RL
J Biol Chem; 2021 Jul; 297(1):100828. PubMed ID: 34048712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
